LEONARDIS, DANIELA
 Distribuzione geografica
Continente #
AS - Asia 1.925
NA - Nord America 913
EU - Europa 392
SA - Sud America 380
AF - Africa 32
OC - Oceania 6
Totale 3.648
Nazione #
SG - Singapore 869
US - Stati Uniti d'America 862
CN - Cina 436
BR - Brasile 306
VN - Vietnam 207
HK - Hong Kong 172
FR - Francia 121
IT - Italia 117
KR - Corea 69
IN - India 34
BD - Bangladesh 31
JP - Giappone 29
DE - Germania 27
AR - Argentina 26
GB - Regno Unito 26
NL - Olanda 21
CA - Canada 19
FI - Finlandia 17
IL - Israele 12
CO - Colombia 11
EC - Ecuador 10
MX - Messico 10
ID - Indonesia 9
RU - Federazione Russa 9
JM - Giamaica 7
UA - Ucraina 7
UY - Uruguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
IQ - Iraq 6
SA - Arabia Saudita 6
TR - Turchia 6
ZA - Sudafrica 6
ES - Italia 5
PE - Perù 5
TT - Trinidad e Tobago 5
AT - Austria 4
AU - Australia 4
EG - Egitto 4
IE - Irlanda 4
KZ - Kazakistan 4
MA - Marocco 4
PL - Polonia 4
PY - Paraguay 4
SE - Svezia 4
TN - Tunisia 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
LK - Sri Lanka 3
LT - Lituania 3
NP - Nepal 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 3.648
Città #
Singapore 550
Santa Clara 281
Hong Kong 171
Hefei 159
Beijing 111
Lauterbourg 98
San Jose 86
Ho Chi Minh City 84
Seoul 69
Ashburn 62
Los Angeles 55
Hanoi 49
New York 39
Dallas 24
Buffalo 22
São Paulo 21
Tokyo 17
Rio de Janeiro 16
Frankfurt am Main 12
Haiphong 10
Minamishinagawa 10
Bari 9
Helsinki 9
Rome 8
Amsterdam 7
Bengaluru 7
Brasília 7
Curitiba 7
Belo Horizonte 6
Da Nang 6
Montevideo 6
Salvador 6
Guangzhou 5
Guayaquil 5
Houston 5
Hải Dương 5
Londrina 5
Milan 5
Munich 5
Newark 5
Orem 5
Portsmouth 5
Tashkent 5
Atlanta 4
Biên Hòa 4
Brooklyn 4
Catania 4
Chennai 4
Dublin 4
Ha Long 4
Lappeenranta 4
London 4
Palermo 4
Porto Alegre 4
Sheffield 4
Stockholm 4
Toronto 4
Turku 4
Bangkok 3
Boston 3
Bắc Ninh 3
Cagliari 3
Camaçari 3
Campinas 3
Can Tho 3
Colombo 3
Contagem 3
Denver 3
Elk Grove Village 3
Florence 3
Guarulhos 3
Hyderabad 3
Kingston 3
Lima 3
Massapequa 3
Miami 3
Nairobi 3
Naples 3
New Delhi 3
Phoenix 3
Piscataway 3
Quận Chín 3
San José 3
Sete Lagoas 3
Sorocaba 3
Sydney 3
Turin 3
Warsaw 3
Abidjan 2
Almaty 2
Amman 2
At Tuwal 2
Avellaneda 2
Baghdad 2
Baku 2
Baltimore 2
Baton Rouge 2
Baturité 2
Belém 2
Bishkek 2
Totale 2.253
Nome #
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method 94
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 86
Neuropeptide y gene polymorphisms and chronic kidney disease progression 77
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis 72
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 72
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease 69
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Verso un sistema di qualità: presentazione delle nuove linee guida della regione Calabria per l'inserimento ed il mantenimento in lista d'attesa per trapianto di rene. 63
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 61
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 60
ROC curve analysis: a useful statistic multi-tool in the research of nephrology 60
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. 59
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 58
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model 58
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients? 57
Creatinine calibration and CKD staging 55
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 54
Sleep Disordered Breathing in Renal Transplant Patients. 53
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve 53
Simple Statistical Measures for Assessing the Accuracy of a Diagnostic Test in Clinical Medicine 51
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 51
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 51
Valore prognostico delle formule di dtims del FG nella popolazione di pazienti con MRC dello studio MAURO. 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 50
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 47
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe 47
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
Circulating E-selectin as a risk marker in patients with end-stage renal disease 43
Differences between GFR estimation by an equation based on creatinine and one based on Cystatine C 43
Neuropeptide Y and chronic kidney disease progression: a cohort study 43
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Semeiotica della pressione arteriosa 39
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 38
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 37
Epidemiology of CKD Regression in Patients under Nephrology Care 36
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 33
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 33
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease 32
La E-selettina è un marker di rischio e interagisce con la flogosi nei pazienti in dialisi. 31
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in ckd patients. 30
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 30
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease 29
Creatinine standardization and CKD staging. 29
Insufficienza renale, ipertensione arteriosa e fattori di rischio cardiovascolare. L'ipertensione arteriosa. Il contributo della ricerca italiana edizione 2007. 29
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 28
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 28
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function 28
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 28
Osteoprotegerina ed aterosclerosi carotidea nei pazienti in dialisi: uno studio di imaging (eco-doppler) e di espressione genica. 27
Il sistema metabolico che regola l'ADMA è presente negli adipociti umani ed è iperespresso nell'insufficienza renale. 27
Osteoprotegerin abd carotid atherosclerosis in uremic patients: an imaging (eco-doppler) and genic expression study 27
Salt intake and inflammation in essential hypertension. 26
Obesity, disease progression and Ramipril renoprotective effects in proteinuric chronic nephropathy: a post-hoc analyses of the REIN Study. 26
Revisione delle linee guida regionali per l inserimento e il mantenimento in lista d attesa per trapianto di rene dei pazienti con insufficienza renale cronica in trattamento sostitutivo (Calabria) 25
Audit sui principali indicatori di procurement e di efficienza del processo di donazione in Calabria. 25
Soluble E-selectin is inversely related to cardiac wall thickness in patients with end stage renal disease . 25
Soluble E-selectin is inversely related to cardiac wall thickness in patients with end stage renal disease (ESRD). 25
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 25
La frequenza della sleep apnea nei trapiantati di rene non differisce da quella della popolazione generale. 25
Stimare il filtrato glomerulare: calibrazione e formule 25
The metabolic syndrome and chronic kidney disease epidemics: severing the link? 24
La sleep apnea ha un'alta prevalenza nell'insufficienza renale cronica di grado moderato severo ed è fortemente associata all'ipertensione notturna e all'aterosclerosi carotidea. 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 24
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 24
Serum phosphate within the normal range predicts the risk of CKD progression 24
Asymmetric Dimethylarginine (ADMA) Enzymatic Machinery and Adipokines Gene Expression in the Adipose Tissue in Stage 3-5 CKD patients. 24
Serum phosphate within the normal range predicts the risk of CKD progression. 24
The full ADMA machinery is expressed in human adipocytes: differential regulation in healthy and uremic man. 24
ADMA machinery is expressed in adipocytes in humans and it is differentially regulated in CKD and ESRD patients 24
Insulin Sensitivity, Systemic Inflammation and Adipose Tissue Gene Expression of Inflammatory Cytokines in Chronic Kidney Disease (CKD) and in Obese Patients. 23
Differences between GFR estimation by a creatinine based equation and one cystatin C based. 23
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 23
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 23
Malattie infettive e Trapianti 23
Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease 23
La fosforemia è un predittore indipendente di progressione della malattia renale cronica? 23
The prevalence of Sleep Disordered Breathing in Renal Transplant Patients Does Not Differ from that in the general population. 23
Osteoprotegerin and carotid atherosclerosis in dialysis patients: an imaging (Eco-doppler) and genic expression study. 23
Metodi di stima del filtrato glomerulare, rischio di progressione della malattia renale e del rischio cardiovascolare nei pazienti con insufficienza renale cronica (IRC). 22
Audit clinico sulle principali aree di intervento della malattia renale cronica: verifica obiettivi linee guida su un campione rappresentativo della popolazione dello studio che ha concluso il periodo di osservazione. 22
Are derived equations to estimate Glomerular Filtration Rate (GFR) in Chronic Kidney Disease ( CKD) patients different in their prognostic value? 22
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 22
Functional correlates and gene expression in fat cells of visfatin/pre-b cell enhancing factor in CKD patients. 22
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients. 22
Searching for Biomarker Patterns Characterizing Carotid Atherosclerotic Burden (AB) in Patients with Reduced Renal Function. 22
Valore prognostico delle formule di stima del FG nella popolazione di pazienti con MRC dello studio MAURO. 22
Renal transplant patients have no excess risk for sleep apnoea. 22
Renal transplant patients have no excess risk for sleep apnoea. 21
Soluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease Patients. 21
Methylarginine enzymatic machinery and Leptin in adipose tissue in CKD patients. 21
La riduzione dell'intake di sale influenza l'infiammazione nell'ipertensione arteriosa essenziale? 21
I livelli circolanti di selettina-E sono inversamente correlati allo spessore delle pareti del ventricolo sinistro nei pazienti dializzati. 21
Serum phosphate within the normal range predicts the risk of CKD progression. 21
Il punto sul progetto MAURO 21
Valore prognostico delle formule di stima del filtrato glomerulare in pazienti con malattia renale cronica. 21
Sleep apnea (SA) is prevalent in chronic kidney disease (CKD) and entails a high cardiovascular risk. 20
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. 20
Osteoprotegerin and carotid atherosclerosis in dialysis patients: an imaging (Eco-doppler) and genic expression study. 20
Systemic and adipose tissue inflammation in chronic kidney disease (CKD) patients. 20
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 20
Totale 3.525
Categoria #
all - tutte 13.301
article - articoli 6.387
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 303
Totale 19.991


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 24 0 7 0
2024/20251.454 12 3 133 90 305 12 28 58 48 43 395 327
2025/20262.163 121 220 203 306 400 63 346 134 109 133 89 39
2026/202782 82 0 0 0 0 0 0 0 0 0 0 0
Totale 3.730